Antares Pharma, Inc. (ATRS)

[ou71764]

There definitely would be a market for a rescue pen to replace a syringe administered treatment for hypoglycemia. But there's no evidence that Pfizer is working with Zealand.

I am disappointed that more detailed information on the deal with Pfizer hasn't been released. I know it's up to Pfizer to decide when to do that. But I'm starting to wonder if there's a snag somewhere. It doesn't appear that anything is imminent.